H.R. 1143

Summary

H.R. 1143, the Medicare IVIG Access Enhancement Act of 2025, was introduced in the House on Feb 7, 2025 by Rep. Adrian Smith (R) with 2 co-sponsors. It was referred to Energy And Commerce, and last saw action on Feb 7, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Record

Text

H.R. 1143 has 2 co-sponsors.

119 HR 1143 IH: Medicare IVIG Access Enhancement Act of 2025
 U.S. House of Representatives
 2025-02-07
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 1143  IN THE HOUSE OF REPRESENTATIVES   February 7, 2025   Mr. Smith of Nebraska  (for himself and  Mr. Garamendi ) introduced the following bill; which was referred to the  Committee on Energy and Commerce , and in addition to the Committee on  Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned   A BILL
To amend title XVIII of the Social Security Act to expand coverage of the in-home administration of intravenous immune globulin under the Medicare program.
1.
Short title
This Act may be cited as the   Medicare IVIG Access Enhancement Act of 2025  .
2.
Expanding coverage of the in-home administration of intravenous immune globulin under the Medicare program
(a)
In general
Section 1861 of the Social Security Act ( 42 U.S.C. 1395x ) is amended—
(1)
in subsection (s)(2)(Z), by inserting  (and, beginning January 1, 2027, for the treatment of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy)  after  primary immune deficiency diseases ; and
(2)
in subsection (zz), by inserting  (or, beginning January 1, 2027, with diagnosed chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy)  after  primary immune deficiency disease .
(b)
Authority for variance in payments
Section 1842(o)(8) of the Social Security Act ( 42 U.S.C. 1395u(o)(8) ) is amended by inserting  and may vary depending on whether such administration is related to treatment of a primary immune deficiency disease or the treatment of chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy (as determined appropriate by the Secretary through notice and comment rulemaking)  after  of 2012 .

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Sponsors

Rep. Adrian Smith (R) sponsors H.R. 1143, and 2 members have co-sponsored it, 1 of them from the day it was introduced.

Adrian Smith

Rep. · R–NE-3 · Sponsor

Introduced Feb 7, 2025

John Garamendi

Rep. · D–CA-8 · Co-sponsor

Joined Feb 7, 2025 · Original

Eugene Vindman

Rep. · D–VA-7 · Co-sponsor

Joined Nov 4, 2025

Show 3 of 3 rows

PreviousNext

Committees

H.R. 1143 went before 2 committees: Ways and Means and Energy and Commerce.

Ways and Means

Ways and Means

Referred To · Feb 7, 2025 · 1,160 Bills

Energy and Commerce

Energy and Commerce

Referred To · Feb 7, 2025 · 1,636 Bills

Actions

H.R. 1143 has taken 2 actions since Feb 7, 2025.

Votes

H.R. 1143 has not gone to a roll call.

Titles

H.R. 1143 goes by 3 titles, 1 of them short titles.

• Medicare IVIG Access Enhancement Act of 2025 — Display Title
• Medicare IVIG Access Enhancement Act of 2025 — Short Title(s) as Introduced
• To amend title XVIII of the Social Security Act to expand coverage of the in-home administration of intravenous immune globulin under the Medicare program. — Official Title as Introduced

Lobbying

2 clients hired 2 firms and 8 registered lobbyists who named H.R. 1143 in 10 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Health Issues, Immigration, Budget/Appropriations, Tariff (miscellaneous tariff bills).

Clients

Who paid to be heard, by how many filings named the bill.

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

Classification

The Congressional Research Service files H.R. 1143 under Health, one of its 31 policy areas, and gives it 5 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 1143’s is Health.

Legislative Subjects

H.R. 1143 carries 5 of CRS’s legislative subjects, from Drug therapy to Neurological disorders.

Source: congress.gov · legiscan.com